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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
1. To assess the impact of altering the availability or proximity of: a) food products (including non-alcoholic beverages); b) alcohol
products; and c) tobacco products on their selection or consumption.
2. For each of the above products, to assess the extent to which the impact of such interventions is modified by: i) study characteristics;
ii) intervention characteristics; and iii) participant characteristics.
B A C K G R O U N D
Description of the condition
Non-communicable diseases, principally cardiovascular diseases,
diabetes, certain forms of cancer and chronic respiratory diseases,
accounted for an estimated 68% of all deaths worldwide in 2012
(WHO 2016). Major risk factors for non-communicable diseases
includemetabolic and dietary risk factors linked to food consump-
tion (e.g. high body mass index, high systolic blood pressure), as
well as smoking and alcohol use - risks that are, in principle, mod-
ifiable. These are also amongst the most significant risk factors for
total disease burden, both globally and in high-income countries
specifically (GBD 2016). Identifying interventions that are effec-
tive in achieving sustained health behaviour change across popula-
tions and countries is therefore one of the most important public
health challenges of the 21st century.
Description of the intervention
It is increasingly recognised that the physical environments that
surround us can exert considerable influences on our health-re-
lated behaviours and that altering these environments may provide
a catalyst for behaviour change (Das 2012; Marteau 2012). In a
recent systematic scoping review, we described a set of interven-
tions that involve altering small-scale physical environments - or
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micro-environments - with the intention of changing health-re-
lated behaviours (Hollands 2013a; Hollands 2013b). Such inter-
ventions, which have also been described as ’choice architecture’
(or ’nudge’) interventions, involve changing characteristics of en-
vironments where people may select or consume food, alcohol or
tobacco including restaurants, workplaces, schools, homes, bars,
pubs, supermarkets or shops. These interventions have received
increased policy and research interest in recent years as a result of
several factors, including shifts in theoretical understanding, and
some supportive empirical evidence (Marteau 2015). Their stand-
ing has also likely been influenced by political acceptability (with
governments preferring ‘light-touch’ rather than legislative or reg-
ulatory approaches) and public acceptability (with preliminary ev-
idence suggesting these types of interventions are relatively accept-
able (Petrescu 2016)). Perceived feasibility and low cost, whereby
such interventions may be viewed as easily implemented at scale,
without complex legislative or regulatory processes, or the need
for individual delivery, may also contribute.
The placement of food, alcohol and tobacco products within the
physical environment can influence their selection and consump-
tion. Within a provisional typology of physical micro-environ-
ment interventions, generated as an outcome of the scoping review
mentioned above (Hollands 2013a), we proposed that ‘placement’
interventions comprise two key, more specific intervention types:
first, interventions that target the ‘availability’ of food, alcohol or
tobacco products within a specific environment - in essence, what
is made available for selection and/or consumption; and second,
interventions focused on how available products are positioned
within a specific environment. Our focus here is on the ‘proximity’
of food, alcohol or tobacco products to and from people, which
can be altered by moving the products nearer or further away to
make them more or less accessible. Availability and proximity in-
terventions are further described below.
Interventions that alter availability
These interventions involve manipulating the available food, alco-
hol or tobacco product options in an environment such as a shop,
bar or restaurant. This can be achieved by providing, either:
a) A greater or lesser range of different product options, for exam-
ple:
• food - providing a wider range of healthier meal options, or
a reduced number of less healthy meal options in a restaurant or
cafeteria; or a reduced range of snacks in vending machines;
• alcohol - providing a wider range of different low-alcohol
options in a bar or pub; or a reduced range of types of wine or
beer in a restaurant; and
• tobacco - providing a reduced range of types of tobacco
product in a shop.
b) A greater or lesser amount (number) of discrete units of a prod-
uct. In this case, the range of different product options might not
be changed, but the number of available units of the existing prod-
uct options is manipulated. For example:
• food - making a lesser amount of (a range of ) chocolate bars
on display in a supermarket;
• alcohol - making a greater amount of (a range of ) low-
alcohol beer bottles available in a bar or pub; and
• tobacco - making a lesser amount of (a range of ) cigarettes
available in a shop.
c) A combination of a) and b).
Interventions that alter proximity
These interventions concern the positioning of products that are
available within that environment. The term we have used - ‘prox-
imity’ - reflects the fact that the predominant intervention of this
type within the current context involves moving food, alcohol or
tobacco products closer to or further away from people, such as
placing a healthier product such as fruit in a more proximal (and
therefore convenient) position within a shop to encourage its pur-
chase (Kroese 2016). By reducing or increasing the distance to
be traversed or reached, such interventions can alter the degree
of convenience, and of effort required for potential consumers to
select or consume these products.
The proximity of a product (how close or far away it is) is al-
tered in relation to key physical features in environments, such as
typical or expected walking routes, building entrances, checkouts
in supermarkets or shops, or seating. Examples include position-
ing a display of food products close to a shop’s entrance (e.g. 1
m), aiming to enable convenient selection of the products, versus
this being located at a distance that requires customers to walk a
greater distance to engage with the display (e.g. 20 m). Alterna-
tively, it could involve altering the positioning of a food product
to be within arm’s reach of a potential consumer (e.g. placed 20
cm from seating) versus requiring them to leave their seating and
walk to take the food product (e.g. placed 2 m from seating).
How the intervention might work
There are considerable influences on behaviour that are beyond
individuals’ deliberative control. Indeed, it has been suggested that
most human behaviour occurs outside of awareness, cued by stim-
uli in environments and resulting in actions thatmay be largely un-
accompanied by conscious reflection (Neal 2006; Marteau 2012;
Hollands 2016). This proposition has led to increasing policy and
research attention being placed on interventions with mechanisms
of action that are less dependent on the conscious engagement
of the recipients, including interventions that involve altering the
placement of objects within the physical environments that sur-
round and cue behaviour.
Various mechanisms of action have been proposed for both avail-
ability and proximity interventions. In relation to availability,
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whether options are available (or absent) within a given environ-
ment inevitably shapes and constrains people’s possible responses.
The more product options that are available, the more likely it is
that an actor will encounter an option they are willing to select
or consume (Chernev 2011), particularly given the ‘mere-expo-
sure’ effect, whereby simple repeated exposure to a product can
elicit increased liking (Dalenberg 2014). Therefore, increasing the
range of options for a given product or category should increase
its selection or consumption - although this is of course subject to
people engaging with the product in the first place, which will be
influenced by many factors, including characteristics of the person
(such as hunger) and of the product (such as its attractiveness or
palatability). It has been suggested that if the range of available
products is increased, choosing between these options becomes
more reliant on a reasoning process, meaning that people may
make different choices based on what they are most able to justify
(Sela 2009). Furthermore, if the range of available product options
remains the same but the number of units of these products in-
creases, this may increase their visibility or salience and therefore
encourage selection or consumption.
In relation to proximity, the central role of physical and men-
tal effort has been highlighted (Wansink 2004; Bar-Hillel 2015).
Humans tend to take the least effortful course of action without
the need for conscious deliberation, and so physical environments
can shape responses by capitalising on this phenomenon. Conse-
quently, products placed nearer an actor require less effort to ob-
tain than those placed farther away and this may correspondingly
impact on motivation to select or consume them (Hunter 2016).
Other than the effort needed (or perceived as such), more distal
products may also be less visible and less salient (Maas 2012).
Increasing physical distance may also increase ‘psychological dis-
tance’ - the subjective experience of distance from the self in that
time and place (Trope 2010) - and so more distal products may be
focused upon in a less detailed way or be subject to more deliber-
ation or rationalisation, which may impact upon one’s behaviour.
Why it is important to do this review
A recent systematic scoping review of evidence for the effects of
physical micro-environment interventions identified a substantial
number of randomised controlled trials that have investigated the
effects of altering the availability and proximity of products on
health-related behaviours (Hollands 2013a). Themajority of these
studies focused on food products, where interventions have signif-
icant potential given the necessity of consumption of these prod-
ucts and their ubiquity within many environments. However, be-
cause both tobacco and alcohol use also involve the selection and
consumption of products, such interventions may also have the
potential to change these behaviours via similar mechanisms. We
propose to synthesise evidence for the effects of availability and
proximity interventions within a single systematic review because
we conceptualise them both as interventions that alter the place-
ment of products within physical micro-environments. To our
knowledge, evidence from these studies has yet to be synthesised
using rigorous systematic review methods that include quantita-
tive synthesis, assessment of risk of bias and investigation of po-
tential effect modifiers, or to encompass alcohol and tobacco use,
although parts of this evidence base have been reviewed (Grech
2015). As such, we do not yet have reliable estimates of the ef-
fects of these types of interventions on product selection and con-
sumption, nor of the influence of factors that may modify any
such effects. Both are necessary to inform the selection and de-
sign of effective public health interventions, particularly given in-
creasing research and policy interest in interventions that alter the
physical environment to make unhealthier behaviours less likely
and healthier behaviours more likely. This interest is evidenced by
the substantial public and policy interest in a previous Cochrane
review on portion, package and tableware size (Hollands 2015),
which has influencedpolicy debate in theUKandAustralia (Public
Health England 2015; Jones 2016).
Poor diet, harmful alcohol use and smoking are socially patterned,
being more common amongst those in lower socioeconomic posi-
tions, thereby contributing to the increased morbidity and prema-
ture mortality observed in these groups (Stringhini 2010). Person-
centred behaviour change interventions, that focus on the provi-
sion of educational information to individuals and encouragement
for them to make active choices, potentially widen health inequal-
ities (Lorenc 2013; McGill 2015). Interventions that instead aim
to alter the environments that people are exposed to and are less
reliant on conscious, reflective engagement (Hollands 2016), may
have greater potential to reduce, or at least not increase, health
inequalities. It has been suggested that this may be because they
rely less on recipients’ cognitive resources including levels of liter-
acy, numeracy and cognitive control, which on average are lower
in population subgroups experiencing higher levels of social and
material deprivation (Spears 2010;Hall 2014). The current review
will seek to identify evidence for differential effects of exposure to
these interventions between socioeconomic groups. To our knowl-
edge, no studies of the effects of these interventions have been con-
ducted in low- and middle-income countries (LMICs) (Hollands
2013a) that would enable a comparison of effects between studies
in high-income countries (HICs) and LMICs, but we will seek
to identify such evidence. Purposively considering socioeconomic
status and country context factors in our analysis (and highlight-
ing gaps in the evidence base) will enable us to draw implications
for the potential of such interventions to impact upon health in-
equalities.
O B J E C T I V E S
1. To assess the impact of altering the availability or proximity of:
a) food products (including non-alcoholic beverages); b) alcohol
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products; and c) tobacco products on their selection or consump-
tion.
2. For each of the above products, to assess the extent to which
the impact of such interventions is modified by: i) study charac-
teristics; ii) intervention characteristics; and iii) participant char-
acteristics.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) or cluster-RCTs with be-
tween-subjects (parallel group) or within-subjects (cross-over) de-
signs, conducted in laboratory or field (‘real world’) settings. We
will exclude non-randomised studies because a recent scoping re-
view indicates that a sufficient number of eligible randomised stud-
ies will be available to enable quantitative synthesis of evidence
for intervention effects using meta-analysis (Hollands 2013a). An
additional consideration is that, compared with RCTs, non-ran-
domised studies rely on more stringent and sometimes non-veri-
fiable assumptions in order to confer confidence that the risk of
systematic differences between comparison groups beyond the in-
tervention of interest (i.e. confounding) is sufficiently low to per-
mit valid inferences about causal effects. If randomised assignment
is not clear in studies considered otherwise eligible for inclusion
at the full-text assessment stage, we will only include the study if
study authors confirm that randomisation occurred.
Types of participants
Adults and children exposed to the interventions. Adults are de-
fined as those 18 years or over, and children defined as those under
18 years (United Nations 1989).We will exclude studies where the
product is being selected and fed directly by one person to another
(e.g. mother-child dyads). We will set no other exclusion criteria
in relation to demographic, socioeconomic or clinical character-
istics. We will exclude studies involving non-human participants
(i.e. animal studies).
Types of interventions
Interventions eligible to be considered in this review are those
that involve altering the availability or proximity of food (includ-
ing non-alcoholic beverages), alcohol or tobacco products within
‘physical micro-environments’ - defined here as small-scale phys-
ical environments where people gather for specific purposes and
activities, such as restaurants, workplaces, schools, homes, bars,
pubs, supermarkets or shops (Swinburn 1999). We define avail-
ability interventions and proximity interventions in Description
of the intervention and provide details of specific eligibility criteria
below.
Availability interventions
‘Availability interventions’ eligible to be considered in this review
are those that involve comparing the effects of exposure to at least
two differing (i.e. higher versus lower) levels of availability of a
manipulated food, alcohol or tobacco product. This will allow us
to examine whether, for example, making a food product more
available increases its consumption, or making a food product less
available decreases its consumption. The ‘product’ can be oper-
ationalised as applying to types of a specific product (e.g. fruit,
chocolate bars) or to broader categories of products (e.g. energy-
dense snack foods; low-fat meals). For alcohol and tobacco prod-
ucts, we will also consider including interventions in which the
availability of specific recognised alternatives to those products
that are not themselves alcohol and tobacco products is manipu-
lated within alcohol or tobacco selection and consumption con-
texts (e.g. alcohol-free variants in the case of alcohol, or e-cigarettes
in the case of tobacco).
Additional inclusion criteria
1. The comparison of different levels of availability must be
explicitly described, as opposed to this being inferred by the
review team. For example, a review author could infer that a
supermarket sales promotion might increase the number of
products on display in store, but a study would only be included
if this alteration was clearly stated by authors.
2. We will include multi-component interventions in which
there are concurrent intervention components that are unrelated
to availability, providing those additional components are
implemented wholly within the same micro-environment as is
the availability intervention, involving changes to the product
itself or its proximal physical environment. Examples include
nutritional labelling on the product itself, or promotional
signage placed near to the product.
We will exclude the following interventions.
1. Multi-component interventions in which there are
concurrent intervention components that are unrelated to
availability, where those additional components are not
implemented wholly within the same micro-environment as is
the availability intervention, involving changes to the product
itself or its proximal physical environment. Examples of such
ineligible intervention components include health education
programmes or marketing campaigns.
2. Interventions in which availability may be altered indirectly
as a result of a higher-level intervention but is not directly and
systematically altered (e.g. organisational-level interventions to
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encourage the wider availability of healthier products within a
workplace or set of workplaces, or national- or regional-level
policy interventions to encourage schools to modify their
environments). While availability may be changed as a result of
the higher-level intervention, this is not directly manipulated to
safeguard implementation fidelity.
3. Interventions within analogue studies that do not
manipulate real food, alcohol or tobacco products but instead
may use written vignettes, computer or questionnaire tasks, or
mock products to assess the impact of altering availability.
4. Interventions in which the range of product options is
unchanged in terms of the different types or categories of
products that are available, but changes are made in the range of
ways in which those same products are formulated or presented
(e.g. flavour, colour, size or shape).
5. Interventions in which the environmental contexts or
opportunities for selection and consumption are not comparable
between intervention and control groups. Therefore, we will
exclude interventions that involve removing (or adding) the
entire range of food, alcohol or tobacco products (e.g. studies
examining the effectiveness within a specified environment of
complete smoking or alcohol bans), as well as those which
involve substantial changes to the infrastructure of the
environment (such as building new shops or restaurants). We
will also exclude interventions in which availability differs
between intervention and control arms due to: additional
exposure to foods via assigned dietary programmes (e.g.
prescribed diets); education (e.g. taste-testing sessions, cooking
lessons or food education); or other means of prescribed
distribution of products to participants.
6. Interventions in which the availability of a product is not
altered in terms of its range or amount but as a result of temporal
(e.g. changing hours of sale or altering a range of available
products over time) or spatial (e.g. changing the places in which
a product can be selected or consumed) factors.
Proximity interventions
‘Proximity interventions’ eligible to be considered in this review
are those that involve comparing the effects of exposure to at least
two differing (i.e. higher versus lower) levels of proximity of a
manipulated food, alcohol or tobacco product.
Whilst there are likely other ways of altering the positioning of
products that do not impact on their proximity, we have purpose-
fully limited our scope to proximity interventions. This is because
any such other studies would be difficult to assess within the same
framework specified for use in the current review, which focuses
on the effects of altering the quantity or degree (i.e. increase versus
decrease) of a specific property (i.e. proximity).
Additional inclusion criteria
1. The comparison of different levels of proximity must be
explicitly described, as opposed to this being inferred by the
review team. For example, a review author could infer that a
redesigned layout of a cafeteria or restaurant might increase or
decrease proximity from a given point of reference, but a study
would only be included if this change in proximity was clearly
stated by authors.
2. As per availability interventions, we will include multi-
component interventions in which there are concurrent
intervention components that are unrelated to proximity,
providing those additional components are implemented wholly
within the same micro-environment as is the proximity
intervention, involving changes to the product itself or its
proximal physical environment. Examples include nutritional
labelling on the product itself, or promotional signage placed
near to the product.
We will exclude the following interventions.
1. (As per availability interventions), multi-component
interventions in which there are concurrent intervention
components that are unrelated to proximity, where those
additional components are not implemented wholly within the
same micro-environment as is the proximity intervention,
involving changes to the product itself or its proximal physical
environment.
2. Interventions in which proximity may be altered indirectly
as a result of a higher-level intervention but is not directly and
systematically altered (e.g. organisational-level interventions to
encourage the redesign of the layout of school or workplace
cafeterias). While proximity may be changed as a result of the
higher-level intervention, this is not directly manipulated to
safeguard implementation fidelity.
3. Interventions within analogue studies that do not
manipulate real food, alcohol or tobacco products but instead
may use written vignettes, computer or questionnaire tasks, or
mock products to assess the impact of altering proximity.
4. Interventions in which the proximity of text, symbols or
images that relate to products is altered (e.g. on a sign,
advertisement, poster, menu, leaflet or computer screen), but the
proximity of the actual products to be selected or consumed is
not.
Types of outcome measures
Eligible studies must incorporate one or more objective measures
of unconstrained selection (with or without purchasing) or con-
sumption of the manipulated food, alcohol or tobacco product(s).
For example, a study investigating the effects of increasing the
availability or proximity of fruit within a shop on healthier pur-
chasing, may include a specific measure of fruit (i.e. the manip-
ulated product) selected only, or a broader measure that encom-
passes both fruit selection and selection of non-fruit options avail-
able in the shop (e.g. a measure of selection of all healthier food
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options). Either would represent an appropriate primary outcome.
Studies may additionally include measures that relate specifically
to non-manipulated products - in the given example there may
also be a measure of selection of non-fruit options only. Such mea-
sures would represent appropriate secondary outcomes.
Objective measurement may involve sales data or calculating the
amount of a product consumed by subtracting the amount re-
maining after consumption from the total amount presented to
the participant. Alternatively, it may involve direct observation of
selection or consumption behaviour by outcome assessors. Sub-
jective measurement would involve participant self-report. By un-
constrained, we refer to behaviour of participants that is not con-
strained or regulated by either explicit instructions or some other
action of the researcher. For example, we will exclude studies that
manipulate the availability of foods that are not selected, plated
or served under the direction of the participant, but where foods
are presented to them individually with the instruction to select
or consume.
Quantities consumed or selected may have been measured over a
time period less than or equal to one day (immediate) or exceed-
ing one day (longer-term). Our choice of eligible outcome con-
structs reflects a focus on the assessment of the effects of eligible
interventions in terms of the types and amounts of food, alcohol
and tobacco people consume, coupled with recognition that the
amount selected (with or without purchasing) is an important in-
termediate endpoint in pathways to consumption.
Primary outcomes
Measures of unconstrained selection (with or without purchasing)
or consumption of themanipulated food, alcohol or tobacco prod-
uct(s). We anticipate encountering a range of measures of these
outcome constructs among included studies, and present the fol-
lowing examples of likely measures below:
1. Selection of a product (a) without purchase, or b) with purchase.
Assessment of the amounts of products (e.g. food, drink, alcohol or
tobacco products), energy or substances (e.g. saturated fat, alcohol,
carbon monoxide) selected, measured in applicable natural units
(e.g. kilojoules, grams). Depending on the study setting, a product
may be selected with or without this involving a purchase, that
is, a transfer of money to the vendor. In cases where there is no
purchasing, selection may be comparable to typical purchasing,
e.g. products being selected in a restaurant or bar where there is no
charge for them, or it may be behaviour that necessarily precedes
consumption in that context, such as serving an amount of a food
product on to a plate or pouring an amount of drink into a glass.
2. Consumption (intake) of a product.
As per selection, assessment of the amounts of products (e.g. food,
drink, alcohol or tobacco products), energy, or substances (e.g.
saturated fat, alcohol, carbon monoxide) consumed, measured in
applicable natural units (e.g. kilojoules, grams).
Secondary outcomes
As with the specified primary outcomes, secondary outcomes are
also measures of unconstrained selection (with or without pur-
chasing) or consumption of food, alcohol or tobacco products.
However, secondary outcomes apply to other products that are
available in the same micro-environment at the same point of se-
lection or consumption as the manipulated product(s), but that
are not themselvesmanipulated as regards their proximity or avail-
ability.
Due to the nature of the interventions, we anticipate that adverse
effects (other than unwanted health-harming effects on selection
or consumption, which will be captured by the specified primary
and secondary outcomes) are unlikely to occur, or be assessed
or reported. However, any adverse events or harms reported in
included studies will be noted.
Conceptual model
To supplement study eligibility criteria, we have developed a pro-
visional conceptual model (Figure 1). The conceptual model is
design-oriented in the sense that it is intended to help direct the
review process (Anderson 2011) by providing a simplified visual
representation of the causal system of interest, i.e. the proposed
causal pathway between eligible interventions and their outcomes
(behavioural endpoints), and potential moderators of that rela-
tionship (effect modifiers) given that differential effects are plau-
sible (Anderson 2013). The provisional conceptual model will be
used to inform the development of search strategies, data extrac-
tion forms and a provisional framework for the statistical analysis
of the data collected from the eligible studies (see Search methods
for identification of studies and Data collection and analysis). We
propose to revise the conceptual model iteratively as we encounter
evidence from eligible studies during the course of the review pro-
cess, and will document all revisions including the rationale for
each revision and supporting evidence. As such, initial and subse-
quent iterations of the conceptual model will be used as a reference
point for the design (in the protocol) and conduct (post-protocol)
of all stages of the systematic review up to and including data syn-
thesis, and as a conceptual basis for explicit reporting of the meth-
ods and assumptions used within the synthesis (Anderson 2013).
We anticipate that, in practice, iterative refinement of the concep-
tual model will primarily involve incorporating further potential
effect modifiers that we encounter when collecting the data from
the eligible studies, which will then be considered for inclusion in
the proposed meta-regression analysis.
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Figure 1. Design-oriented conceptual model
Within the provisional conceptual model (Figure 1), we distin-
guish between three sets of potential effect modifiers: study char-
acteristics; intervention characteristics; and participant character-
istics. Within our proposed analytic framework for quantitative
synthesis of data collected from the included studies (see Data
collection and analysis), potential effect-modifying impacts of
study characteristics can only be investigated based on between-
study comparisons, whereas potential effect-modifying impacts of
intervention characteristics can be investigated based on within-
study comparisons between participant groups (for example, be-
tween different arms of an RCT). Potential effect-modifying im-
pacts of participant characteristics may be investigated based on
either between-study comparisons or within-study comparisons,
depending on the level of reporting of results by participant sub-
groups among included studies.
Search methods for identification of studies
Electronic searches
We developed a MEDLINE search strategy by combining sets of
controlled vocabulary and free-text search terms based on the eligi-
bility criteria described above (see Criteria for considering studies
for this review). It was developedwith the intention of being highly
sensitive (at the expense of precision) to give confidence in its
ability to detect potentially eligible title and abstract records. This
search strategy was externally peer-reviewed by an information re-
trieval specialist and co-convenor of the Cochrane Information
Retrieval Methods Group and revised based on their peer-review
comments. We tested and calibrated the MEDLINE search strat-
egy for its sensitivity to retrieve a reference set of 24 records of
reports of potentially-eligible studies that were identified within a
preceding, broader scoping review of interventions within physi-
cal micro-environments (Hollands 2013a). In addition, the search
strategy was then reviewed by the Information Specialist of the
Cochrane Public Health Group and further revised based on their
comments. The final MEDLINE search strategy is presented in
Appendix 1. We then adapted the final MEDLINE search strat-
egy for use to search each of the other databases listed based on
close examination of the database thesauri and scope notes. There
were no restrictions for publication date, publication format or
language. No study design filters were incorporated. Full details
of the final search strategies will be provided in an appendix to the
published review.
Wewill conduct electronic searches for eligible studies within each
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of the following databases:
• MEDLINE (including MEDLINE In-Process) (OvidSP)
(1946 to present);
• Embase (OvidSP) (1980 to present);
• PsycINFO (OvidSP) (1806 to present);
• Cochrane Central Register of Controlled Trials
(CENTRAL) (1992 to present);
• Applied Social Sciences Index and Abstracts (ASSIA)
(ProQuest) (1987 to present);
• Science Citation Index Expanded (Web of Science) (1900
to present);
• Social Sciences Citation Index (Web of Science) (1956 to
present); and
• Trials Register of Promoting Health Interventions (EPPI
Centre) (2004 to present).
Searching other resources
Wewill conduct electronic searches of the following grey literature
databases using search strategies adapted from the finalMEDLINE
search strategy as described above:
• Conference Proceedings Citation Index - Science (Web of
Science) (1990 to present);
• Conference Proceedings Citation Index - Social Science &
Humanities (Web of Science) (1990 to present); and
• OpenGrey (1997 to present).
We will search trial registers (ClinicalTrials.gov, the World Health
Organization (WHO) International Clinical Trials Registry Plat-
form (ICTRP), and the EU Clinical Trials Register) to identify
registered trials, and the websites of key organisations in the area
of health and nutrition including the following:
• UK Department of Health;
• Centers for Disease Control and Prevention (CDC), USA;
• World Health Organization (WHO);
• International Obesity Task Force; and
• EU Platform for Action on Diet, Physical Activity and
Health.
In addition, we will search the reference lists of all eligible study
reports and undertake forward citation tracking (using Google
Scholar) to identify further eligible studies or study reports. If non-
English language articles are found, we will use Google Translate
in the first instance to determine potential eligibility. If an article
cannot be excluded on this basis, we will aim to have the article
translated by a native language speaker or professional translation
service.
Data collection and analysis
Selection of studies
Title and abstract records retrieved by the electronic searches will
be imported into EPPI Reviewer 4 (ER4) systematic review soft-
ware (Thomas 2010). Duplicate records will be identified, re-
viewed manually and removed using ER4’s automatic de-duplica-
tion feature.
In relation to the electronic searches, search terms based on rele-
vant intervention and comparator concepts (for example, availab$,
increas$, add$, introduc$, close$, near$, far$) are unlikely to be
specific to title-abstract records of eligible studies (even when con-
figured in multi-strand search strategies); they are also likely to
feature frequently in irrelevant title-abstract records. This is likely
to result in large numbers of records being retrieved by electronic
searches, which need to have sufficient sensitivity to capture all
eligible studies. To address this challenge, we will use a semi-auto-
mated screening workflow to manage the title-abstract screening
stage, deployed in ER4, which will use machine learning to assign
title-abstract records for duplicatemanual screening (O’Mara-Eves
2015). This workflow is designed to maximise recall of eligible
studies while reducing screening workload to match the available
resource, which we expect to allow for duplicate manual screening
of up to a maximum of one third of retrieved records (the ‘overall
screening budget’). Further details of the semi-automated screen-
ing workflow are provided in Appendix 2.
Two review authors, working independently, will undertake du-
plicate screening of title and abstract records retrieved by the elec-
tronic searches. Title and abstract records will be coded as ‘provi-
sionally eligible’, ‘excluded’ or ‘duplicate’ by applying the eligibil-
ity criteria described above (see Criteria for considering studies for
this review). Any disagreements in the coding of title and abstract
records will be identified and resolved by discussion to reach a
consensus between the two review authors. If they are unable to
reach a consensus, a third author will act as arbiter.
Full-text copies of corresponding study reports will be obtained
for all records coded as ‘provisionally eligible’ at the title and ab-
stract screening stage.Duplicate screening of full-text study reports
will be undertaken by two review authors working independently.
Full-text study reports will be coded as ‘eligible’ or ‘excluded’ by
applying the eligibility criteria described above (see Criteria for
considering studies for this review), with the reasons for exclusion
recorded. Any disagreements in the coding of full-text study re-
ports or reasons for exclusion will be identified and resolved by
discussion to reach consensus between the two review authors.
In the event that any coding disagreements cannot be resolved,
a third author will act as arbiter. Bibliographic details of study
reports excluded at the full-text screening stage will be provided,
along with the primary reason for exclusion, in a ’Characteristics
of excluded studies’ table within the published review. Multiple
full-text reports of the same study will be identified, linked and
treated as a single study. Full-text reports comprising multiple eli-
gible studies will be identified and each study will be treated sepa-
rately. We will document the flow of records and studies through
the systematic review process and report this using a PRISMA flow
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diagram (Moher 2009).
Data extraction and management
An electronic data extraction form will be developed based on the
Cochrane Public Health template and the form used in a previous
Cochrane review (Hollands 2015), modified to allow extraction
of all data required for this review. An initial draft of this form will
be piloted using a selection of included studies, to ensure that it
enables reliable and accurate extraction of appropriate data, and
amended in consultation with the review team. Data pertaining
to the characteristics of included studies will be extracted by one
review author. Outcome data will be extracted in duplicate by two
review authors working independently. If a study with more than
two intervention arms is included, only outcome data pertaining
to the intervention and comparison groups that meet the eligi-
bility criteria described above will be included in the review, but
the table ’Characteristics of included studies’ will include details
of all intervention and comparison groups present in the study.
Any discrepancies in extracted outcome data will be identified
and resolved by checking against the study report, discussion and
consensus between two review authors, with a third author act-
ing as arbiter in case of any unresolved discrepancies. Key unpub-
lished data that are missing from reports of included studies will
be sought by contacting the study authors.
At the outset we intend to collect the data summarised below.
This represents a maximum core dataset that we can reasonably
anticipate will be required based on our study eligibility criteria
and the design-oriented conceptual model (Figure 1). This dataset
will likely evolve as the review develops. For example, the process
of extracting data from the included studies may identify unan-
ticipated potential effect modifiers (moderators or mediators) that
prompt revisions to our design-oriented conceptual model, as de-
scribed above. This dataset relates to the process of data extraction
only and, as such, not all of these variables will be included in the
statistical analysis process.
Study characteristics
1. Study design: between-subjects or within-subjects design;
individually or cluster randomised
2. Geographical setting: country
3. Study (intervention) setting: laboratory; field
4. Intervention type: availability; proximity (and, if applicable,
type of availability intervention (e.g. range of options; amount
(number) of units; combination) or type of proximity
intervention (distance altered from which feature, e.g. seating;
walking route; checkout; entrance))
5. Product type: food; alcohol; tobacco
6. If applicable, energy (calorie) or macronutrient content of
product
7. If applicable, selection with purchasing or selection without
purchasing
8. Duration of exposure
9. Relationship between manipulated product and outcome
(how outcome maps on to manipulated product)
10. Relationship between manipulated product and other
available products (for example, changes to the availability of a
product may be accompanied by increases, decreases or no
changes in the availability of other products. Coding schemes for
characterising such different permutations will be developed
iteratively based on the nature of studies that are encountered)
11. Concurrent intervention component in factorial design
12. Concurrent intervention components confounded with
comparison of interest
13. Socioeconomic status context
14. Summary ’Risk of bias’ assessments
15. Information on funding source and potential conflicts of
interest from funding
Intervention characteristics
1. If applicable, magnitude of relative difference in availability
(range, amount)
2. If applicable, magnitude of absolute difference in
availability (range, amount)
3. If applicable, magnitude of relative difference in proximity
4. If applicable, magnitude of absolute difference in proximity
Participant characteristics
1. Age/age group
2. Sex/gender (e.g. male, female)
3. Ethnicity
4. Socioeconomic status (e.g. occupational status; education;
income; food insecurity; welfare receipt)
5. Body mass index (BMI); body weight; body weight status
6. Behavioural characteristics (e.g. dietary restraint; dietary
disinhibition; level of intake or dependence, for targeted product)
7. Biological state (e.g. hunger)
These participant characteristics cover several categories of so-
cial differentiation relevant to health equity. The incorporation of
study-level data on these participant characteristics into our pro-
posed meta-regression analysis (see Data synthesis) is in part in-
tended to enable us to draw inferences concerning any differential
effects of the intervention on health equity (Welch 2012). For ex-
ample, within our proposed meta-regression (see Data synthesis)
we intend to enter proxy measures of socioeconomic status as par-
ticipant characteristics that may moderate the observed effects of
the intervention on product selection and consumption. In ad-
dition, to complement investigations based on participant char-
acteristics, we will use the most commonly available measure of
socioeconomic status to construct a binary study-level covariate of
‘socioeconomic status context’ (see ‘Study characteristics’, above)
that will serve as a proxy for the overall study context in terms of
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baseline levels of social and material deprivation amongst study
participants. Analysis of this study-level covariate as a potential
effect modifier will allow us to investigate specifically whether el-
igible interventions are more or less effective in a study context
characterised by high versus low levels of social and material de-
privation. In practice, given experience with a previous Cochrane
review in a similar area (Hollands 2015), we consider it unlikely
that any single proxy measure of participants’ socioeconomic sta-
tus, such as education or income, will be commonly measured in
and reported by included studies, and it is likely that we will be
limited to coding a study-level covariate based on authors’ explicit
descriptors of the study sample and/or setting.
Outcome data
It is anticipated that some eligible primary studies will include
more than one eligible measure of selection or consumption. We
will use the measure of selection or consumption that maps most
closely on to the focus of the intervention, e.g. where only fruit
products have been manipulated, we will, if possible, use a mea-
sure that relates specifically to fruit selection or consumption only.
Where multiple products have been manipulated, we will, if pos-
sible, use a measure that either relates specifically to one of those
products (if it was discernible that that product was the primary
intervention focus), or captures consumption or selection of all
manipulated products. If a study includes only a measure that cap-
tures selection or consumption of a wider set of products beyond
those that have been manipulated (but including the manipulated
product), this would still represent an eligible outcome for the
purposes of this review, but would be considered less desirable be-
cause it may require assumptions to be made about the direction
of effect in relation to the manipulated product itself. Following
the application of these criteria, if there remain multiple eligible
outcome measures, we will select the single measure of selection
or consumption that has been (pre)specified by study authors as
the primary outcome. If no primary outcome has been specified
by study authors, we will select the measure of selection or con-
sumption most proximal to health outcomes in the context of the
specific intervention. For example, if a study reports measures of
both energy intake and the amount of food eaten (in grams), we
will select energy intake as the measure most proximal to diet-
related health outcomes.
For all outcome data, we will collect information on: outcome
variable type (dichotomous, continuous); outcome variable defi-
nition; unit of measurement (if relevant); timing of measurement
(immediate (≤ 1 day) or longer term (> 1 day)); and type of mea-
sure (objective, self-report). For dichotomous outcomes we will
extract event rates in each comparison group. For continuous out-
comes we will extract mean differences, or mean changes in final
measurements from baseline measurements, for each comparison
group with associated standard deviations (or, if standard devi-
ations are missing, standard errors, 95% confidence intervals or
relevant t-statistics, f-statistics or P values), and we will also in-
dicate whether a high or low value is favourable from a public
health perspective. For included studies using factorial designs to
investigate the effects of multiple experimental manipulations, we
will combine groups to capture the main effects of each relevant
randomised comparison.
Assessment of risk of bias in included studies
Risk of bias in the included studies will be assessed using the re-
vised Cochrane ’Risk of bias’ tool for randomised trials (RoB 2.0)
(Higgins 2016a), using the additional guidance for cluster-ran-
domised (Eldridge 2016) and cross-over trials (Higgins 2016b)
should we identify eligible studies using these designs. RoB 2.0
addresses five specific domains: (1) bias arising from the randomi-
sation process; (2) bias due to deviations from intended interven-
tions; (3) bias due to missing outcome data; (4) bias in measure-
ment of the outcome; and (5) bias in selection of the reported
result. The tool will be applied to each included study by two re-
view authors working independently, and supporting information
and justifications for judgements of risk of bias for each domain
(low; high; some concerns) will be recorded, and where possible,
will include verbatim text extracted from study reports. Any dis-
crepancies in judgements of risk of bias or justifications for judge-
ments will be identified and resolved by discussion to reach con-
sensus between two review authors, with a third author acting as
arbiter in the case of any unresolved discrepancies. Following guid-
ance given for RoB 2.0 (Section 1.3.4) (Higgins 2016a), we will
derive an overall, summary ’Risk of bias’ judgement (low; high;
some concerns) for each specific outcome, based on those domains
judged to be most critical in this specific review. This means that
we will only judge summary risk of bias to be ’low’ if judgements
in all of these domains are ’low (risk of bias)’. Completed ’Risk
of bias’ tables will be presented in the published review, including
justifications for each judgement.
We will include a summary assessment of risk of bias for each
specific outcome included in our statistical analysis as a covariate in
our proposedmeta-regression analysis (seeData synthesis).Wewill
also consider the summary risk of bias in determining the strength
of inferences drawn from the results of the data synthesis and in
developing conclusions and any recommendations concerning the
design and conduct of future research.
Measures of treatment effect
For continuous outcomes, we will calculate the standardised mean
difference (SMD) with 95% confidence intervals to express the
size of the intervention effect in each study relative to the variabil-
ity observed in that study. For dichotomous outcomes, we will cal-
culate the odds ratio (OR) for each included study to express the
size of the relative intervention effect between comparison groups,
with the uncertainty in each result being expressed by the confi-
dence interval. We will then re-express the odds ratio as an SMD
10Altering the availability or proximity of food, alcohol and tobacco products to change their selection and consumption (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
by applying the formula described in Section 9.4.6 of theCochrane
Handbook for Systematic Reviews of Interventions (Deeks 2011).
Unit of analysis issues
In the case of cluster-randomised trials, where an analysis is re-
ported that accounts for the clustered study design, we will esti-
mate the effect on this basis, using reported test statistics (t-statis-
tics, F-statistics or P values) to calculate standard errors if neces-
sary. If this is not possible and the information is not available
from the authors, then an ’approximately correct’ analysis will be
carried out according to current guidelines (Higgins 2011). We
will impute estimates of the intra-cluster correlation (ICC) using
estimates derived from similar studies or by using general recom-
mendations from empirical research. If it is not possible to imple-
ment these procedures, we will give the effect estimate as presented
but report the unit of analysis error.
For included studies with a within-subjects design, we will cal-
culate the SMD for continuous outcomes using the methods de-
scribed in Section 16.4 of the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011), and compute standard er-
rors for outcome data using reported test statistics or estimates of
correlation, as for cluster-randomised trials, if necessary. Final out-
come values will serve as the primary unit of analysis. For studies
assessing changes from baseline as a result of an experimental ma-
nipulation, we will calculate final values based on either reported
data or supplementary data obtained by contacting study authors,
if available.
In relation to potential unit of analysis issues arising from studies
with multiple eligible comparison groups, our detailed plans are
provided below under Data synthesis.
Dealing with missing data
Data that are missing from reports of included studies will be
sought by contacting the study authors. Where data are missing
due to participant dropout we will conduct available case analyses
and record any issues of missing data within ’Risk of bias’ assess-
ments.
Assessment of heterogeneity
We will assess statistical heterogeneity in results by inspecting a
graphical display of the estimated treatment effects from included
studies along with their 95% confidence intervals, and by formal
statistical tests of homogeneity (Chi2) and measures of inconsis-
tency (I2) and heterogeneity (τ 2).
Assessment of reporting biases
We will draw funnel plots (plots of effect estimates versus the
inverse of their standard errors) to inform assessment of reporting
biases. We will conduct statistical tests to formally investigate the
degree of asymmetry using the method proposed by Egger et al
(Egger 1997). Results of statistical tests will be interpreted based
on visual inspection of the funnel plots. Asymmetry of the funnel
plot may indicate publication bias or other biases related to sample
size, though it may also represent a true relationship between trial
size and effect size.
Data synthesis
We will describe and summarise the findings of included studies
to address the objectives of the review. We will provide a narrative
synthesis describing the interventions, participants, study charac-
teristics and effects of eligible interventions upon prespecified out-
comes (see Criteria for considering studies for this review), and
will consider presenting the narrative syntheses in disaggregated
form by type of product: food, alcohol and tobacco. Our statis-
tical analysis of the results of included studies will use a series of
random-effects and fixed-effect models to estimate summary ef-
fect sizes as SMDs with 95% confidence intervals in terms of each
specified outcome. The precise configuration of our proposed sta-
tistical analysis will be determined based on the final iteration of
our design-oriented conceptual model. Our statistical analysis will
comprise the following stages.
• Stage 1: conduct separate meta-analyses for each product
type (food, alcohol and tobacco) and, within each product type,
conduct separate meta-analyses for (i) availability interventions
and (ii) proximity interventions.
Then for each meta-analysis:
• Stage 2: conduct a meta-regression analysis with study
characteristics as additional covariates.
• Stage 3: conduct a meta-regression analysis with
intervention characteristics as covariates.
• Stage 4: conduct a meta-regression analysis with participant
characteristics and summary risk of bias as covariates.
Study-level effect sizes that are calculated based on outcome data
from independent within-study comparisons will be directly in-
corporated into Stage 1 meta-analyses. For studies that include
three or more eligible comparison groups (for example, an in-
cluded study of a proximity intervention measured energy con-
sumed from a food product placed either 1 m, 2 m or 3 m from
participants), we will treat each eligible within-study comparison
as providing independent outcome data. We will use data from
incremental comparisons only (for example, 1 m versus 2 m and
2 m versus 3 m; but not 1 m versus 3 m). We will consider han-
dling the dependency betweenmultiple comparisons in one of two
ways. First, we will incorporate all comparisons into a single (uni-
variate) meta-analysis (or meta-regression). Such a meta-analysis
assumes a linear ’dose-response’ relationship between the size of
the experimental manipulation and amounts consumed/selected.
In such an analysis, we will halve the sample sizes of groups that
feature in two incremental comparisons (for example, the 2 m
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group features in both the 1 m versus 2 m comparison and the 2
m versus 3 m comparison), to adjust corresponding study weights
in the analysis. Alternatively, we may decide to undertake multi-
variate analysis to deal with studies with multiple treatment arms,
so that direct comparisons between each treatment arm and a con-
trol condition can be modelled, using mvmeta (White 2011). The
decision between a univariate and a multivariate approach will be
contingent on the extent to which outcome data are available from
studies with multiple treatment arms (that is, if there are few or
no included multi-arm studies, multivariate analysis may not be
appropriate).
A covariate will be excluded from Stages 2, 3 or 4 of a meta-re-
gression analysis if useable data are available from fewer than 10
eligible studies incorporated into the corresponding Stage 1 meta-
analysis, and/or covariate values do not enable sufficient discrim-
ination between studies (for example, if covariates are identical,
with all included studies using a between-subjects design and ran-
domising individual participants). Within each stage of a meta-
regression analysis, we will test each covariate separately to identify
those variables statistically associated with each outcome. Finally,
wewill estimate and present ameta-regressionmodel that incorpo-
rates the set of covariates that best explains statistical heterogeneity
observed in the corresponding Stage 1 meta-analysis. We will use
the following procedure to select and incorporate covariates into
this multi-variable model:
1. rank those covariates identified as potentially important
predictors of the outcome in Stages 2, 3 or 4 in order of the
corresponding adjusted R2 values;
2. starting with the top-ranked covariate, use a stepwise
procedure to add each consecutively ranked covariate into the
multi-variable meta-regression model; and
3. retain a covariate in the multi-variable model only if it
increases the adjusted R2 for the multi-variable and no
collinearity or multicollinearity with other retained covariates is
detected.
For each covariate represented as a categorical or binary variable
and retained in the final multi-variable meta-regression model,
we will also estimate and present summary effect sizes for each
subgroup. For each covariate represented as a continuous variable
and retained in the final model, we will present a bubble plot to
illustrate the statistical association.
Treatment of multi-component studies
For included studies using factorial designs to investigate the effects
ofmultiple experimentalmanipulations, wewill combine outcome
data across groups to capture the main effect attributable to each
‘availability’ or ‘proximity’ comparison.
We also anticipate encountering studies of interventions with con-
current components that are unrelated to but intrinsically con-
founded with themanipulations of interest (namely product avail-
ability or proximity). For these studies, we will treat the presence
of concurrent components as a study characteristic. At minimum
we will code all included studies using a dummy variable that
represents the presence or absence of one or more additional in-
tervention components (although we may iteratively develop a
more detailed coding scheme should sufficiently similar concur-
rent components (and combinations thereof ) be replicated across
multiple studies). Our primary analyses will exclude comparisons
where confounded components are present. We will subsequently
conduct sensitivity analyses whereby these comparisons will be re-
instated, in order to assess their impact on the results.
Certainty of evidence
We will use the standard GRADE system to rate the certainty of
each body of evidence incorporated into meta-analyses for (1) se-
lection (with or without purchasing) and (2) consumption out-
comes, in terms of the confidence that may be placed in summary
estimates of effect. Within the GRADE approach, the certainty of
a body of evidence for intervention effects is assessed based on the
design of the underlying studies - with RCTs initially considered
high certainty - and on a number of factors that can decrease or
increase certainty. GRADE criteria for downgrading certainty of
evidence encompass study limitations, inconsistency, imprecision,
indirectness, publication bias, and other considerations (Balshem
2011). If such a criterion is identified, it is classified either as seri-
ous (leading to downgrading by one level) or very serious (down-
grading by two levels). The four possible certainty ratings that can
be applied range from high certainty (meaning that further re-
search is very unlikely to change the estimate of effect) through to
moderate certainty, low certainty and very low certainty (meaning
that any estimate of effect is uncertain and is very likely to change
with the integration of further study results).
’Summary of findings’ tables
A series of ’Summary of findings’ tables developed using GRADE-
pro GDT (Brozek 2008) will be presented. They will comprise
summaries of the estimated intervention effect and the number
of participants and studies for each outcome, encompassing un-
constrained selection or consumption of manipulated products
(primary outcomes) and non-manipulated products (secondary
outcomes). They will also include the justifications underpinning
all GRADE assessments. We will present separate summary effect
sizes and certainty of evidence ratings for food, alcohol and tobacco
products, and for availability and proximity interventions within
each of these product types. Results of meta-analyses will be pre-
sented as SMDs with 95% confidence intervals (CIs). To facilitate
interpretation of these estimated effect sizes, we will also re-express
them using selected familiar metrics of food, alcohol or tobacco
selection or consumption (for example, in relation to average daily
energy intake) using observational data from a population-repre-
sentative sample in at least one jurisdiction (Schünemann 2011;
Hollands 2015).
Sensitivity analysis
In addition to the aforementioned treatment of studies featuring
confounded additional intervention components, sensitivity anal-
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yses will be conducted to explore the impact of any outcome data
that are imputed due to missing data.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. *Beverages/
2. *Alcohol Drinking/
3. (drink$ or drunk$ or alcohol$ or beverage$1 or beer$1 or lager$1 or wine$1 or cider$1 or alcopop$1 or alco-pop$1 or spirit or
spirits or liquor$1 or liquer$1 or liqueur$1 or whisky or whiskey or whiskies or whiskeys or schnapps or brandy or brandies or gin or
gins or rum or rums or tequila$1 or vodka$1 or cocktail$1).ti,ab.
4. *Tobacco/
5. *Smoking/
6. (cigar$ or smok$ or tobacco$ or e-cig$).ti,ab.
7. *Diet/
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14. *Food Dispensers, Automatic/
15. (nutri$ or calori$ or food$ or eat or eats or eaten or eating or ate or low-fat or meal$ or dessert$1 or snack$ or drink$ or
beverage$1).ti,ab.
16. ((increase$1 or increasing or add$1 or added or adding or addition$1 or additional or introduce$1 or introduction$1 or introducing
or extend$ or reduc$ or decrease$1 or decreasing or remov$ or restrict$ or limit$ or proxim$ or distal or distanc$ or position$ or
reposition$ or visib$ or accessib$ or close or closer or closest or near or nearer or nearest or adjacent or far or farther or farthest or
farthermost or further or furthest or furthermost) adj3 (amount$1 or volume$1 or quantity or quantities or availab$ or range$ or
assortment$1 or arrangement$1 or array$ or display$ or choice$1 or option$ or item$1 or effort or convenien$ or salien$ or product$1
or packag$ or portion$ or serving$ or glass or glasses or bottle$ or dish$2 or bowl$1 or plate$1 or box or boxes or boxed or bag or bags
or bagged or packet$ or carton$1 or vending$)).ti,ab.
17. ((increase$1 or increasing or add$1 or added or adding or addition$1 or additional or introduce$1 or introduction$1 or introducing
or extend$ or reduc$ or decrease$1 or decreasing or remov$ or restrict$ or limit$ or proxim$ or distal or distanc$ or position$ or
reposition$ or visib$ or accessib$ or close or closer or closest or near or nearer or nearest or adjacent or far or farther or farthest or
farthermost or further or furthest or furthermost) adj3 (food$ or fruit$ or vegetable$ or FV or FFV or F&V or low-fat or meal$ or




21. 16 and 18
22. 16 and 19
23. 16 and 20
24. or/17,21-23
25. exp animals/ not humans/
26. (rat or rats or mouse or mice or murine or rodent or rodents or hamster or hamsters or pig or pigs or porcine or rabbit or rabbits
or animal or animals or dog or dogs or cat or cats or cow or cows or bovine or sheep or ovine or monkey or monkeys).ti,ab.
27. or/25-26
28. 24 not 27
29. (editorial or case reports or in vitro).pt.
30. 28 not 29
Appendix 2. Details of the semi-automated screening workflow
The semi-automated screening workflow will proceed in four phases: i) Initial sample; ii) Active learning; iii) Topic modelling; iv)
Active learning (final phase).
Initial sample
First, we will screen a random sample of title-abstract records to establish an initial estimate of the baseline inclusion rate (Shemilt
2014), in order to both inform prospective monitoring of the performance of the semi-automated screening workflow, and supply an
unbiased initial sample of records for machine learning (see Active learning).
Active learning
Second, we will deploy active learning with the aim of identifying records of potentially eligible studies as rapidly as possible. In this
phase, title-abstract records will be prioritised for manual screening using active learning, whereby the machine iteratively ‘learns’ to
distinguish between relevant and irrelevant records in conjunction with manual user input (Miwa 2014). We have previously deployed
this method in two large-scale systematic scoping reviews of interventions to change health behaviour (Shemilt 2013; Hollands 2013a;
Shemilt 2014). Active learning will initially be trained using small samples of provisionally included and excluded records drawn from
a reference set of 24 records of potentially eligible studies identified by a published scoping review on physical micro-environment
interventions (Hollands 2013a) or in the random sample of citations screened in phase 1 (Initial sample). In order to deploy active
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learning, a stopping criterion is needed that prespecifies when this phase will be truncated. We have set the stopping criterion in
terms of the maximum marginal resource the review team is willing to ‘pay’ in order to identify one additional title-abstract record
of a potentially eligible study. We will prospectively monitor and record screening time-on-task and stop the active learning phase of
the semi-automated workflow if the review authors complete 15 hours of duplicate screening (i.e. 30 hours time-on-task in total for
two review authors) without identifying any further records of potentially eligible studies. At this point, we will also screen a second
random sample of records to establish a second estimate of the baseline inclusion rate (Shemilt 2014). In this active learning phase of
the workflow, we will also alternate between title-abstract and full-text screening stages after each set of 2400 title-abstract records has
been manually screened. This is intended to promote more accurate initial title-abstract screening decisions, and to enable retrospective
modelling of the impact of using full-text screening decisions in training data for active learning.
Topic modelling
Active learning can be expected to have identified the large majority of title-abstract records of potentially eligible studies that are
present in the full set retrieved by electronic searches before the above stopping criterion for that phase is enacted. However, given that
active learning iteratively prioritises further title-abstract records for screening based on the researchers’ preceding eligibility decisions
about records that were also prioritised by active learning (that is, the algorithm progressively finds ‘more of the same’), we will next
introduce an entirely different, novel method into the semi-automated workflow, in order to provide a check and balance on the use of
active learning alone. In this third phase of title-abstract screening, records will be allocated for duplicate manual screening based on
topic modelling using Latent Dirichlet Allocation (LDA) (Pedregosa 2011). Topic modelling essentially clusters title-abstract records
according to the combinations of terms they contain and returns a set of ’topic terms’ for each cluster (hereafter, a ‘topic’).
Topic modelling will be used to generate 50 topics underlying the full set of title-abstracts retrieved by electronic searches (or included
among the reference set), and concurrently to generate a series of ‘membership scores’ for each unscreened record, by topic. The
membership score is based on the computed probability that a record is described by the topic (that is, a higher membership score
reflects a higher probability of membership of the topic) and is > 0 for all records in all topics. Each unscreened title-abstract record
will next be allocated to the single topic that corresponds with its highest membership score. Results of a preliminary simulation study,
conducted to simulate this phase of the workflow in a screening dataset curated from another Cochrane review (Hollands 2015),
indicated that the large majority of generated topics contained no unscreened records of potentially eligible studies (that is, most topics
are irrelevant), and also that the review authors were able to discriminate accurately between topics that contained the most and fewest
records of potentially eligible studies when blinded to this information. Two review authors will therefore next examine each topic,
blinded to the number of records allocated to each, and place the 50 topics in rank order based on their inter-subjective judgement
of the likelihood that each set of terms describes a set of records that includes eligible studies. A second ranking of the 50 topics will
also be generated based on the number of potentially eligible title-abstract records each contains among records already screened up to
the end of the active learning phase (that is, a data-generated ranking). We will then compute a composite ranking by adding together
the review authors’ ranking and the data-generated ranking, once the latter has been multiplied by 0.5. This procedure assigns double
weight to the review authors’ judgements in the composite ranking, promoting those topics that the review authors rank higher but
contain a relatively low number of potentially eligible title-abstract records among those already screened (and, conversely, demoting
those topics that the authors rank lower but contain a relatively low number of potentially eligible title-abstract records among those
already screened).
At the end of the active learning phase, the ‘remaining screening budget’ (that is, the ‘overall screening budget’ minus the number
of records already screened) will be calculated and allocated between topics, by drawing a random sample of unscreened title-abstract
records from each topic (that is, the sum of the sizes of the 50 random samples will equal the remaining screening budget). The sizes
of random samples drawn from topics will be scaled to approximate a beta distribution (α=0.3, β=3.0) across rank-ordered topics
(highest to lowest), in order to reflect our prior belief (informed by results of the simulation study) about the likely distribution of any
further potentially eligible title-abstract records across rank-ordered topics. Sampled records will next be allocated for duplicate manual
screening in topic rank order, from highest to lowest ranked. This procedure will ensure that records assigned to a higher ranked topic
will be more likely to be allocated for screening, relative to those assigned to a lower ranked topic. We will continue the topic modelling
phase of title-abstract screening until either all records allocated using the above procedure have been screened, or the following early
stopping criterion is enacted: based on prospective monitoring of time-on-task, we will truncate this phase of the semi-automated
screening workflow if the review authors complete 15 hours of duplicate screening (i.e. 30 hours time-on-task in total for two authors)
without identifying any further records of potentially eligible studies.
Active learning (final phase)
Because the topic modelling phase may detect additional title-abstract records that alter any subsequent prioritisation of records by
active learning, we will conduct a final phase of screening using the active learning method outlined above. Again, we will truncate this
phase of the semi-automated screening workflow if the review authors complete 15 hours of duplicate screening (i.e. 30 hours time-
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on-task in total for two authors) without identifying any further records of potentially eligible studies. Including this further phase will
give additional confidence that, within available resources, all relevant title-abstract records have been identified.
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